Amarillo researchers identify promising compounds to treat neurodegenerative diseases
Abraham Al-Ahmad and Paul Trippier
A study published in the November issue of the Journal of Medicinal Chemistry, the nation’s leading medicinal chemistry journal, describes new compounds designed and synthetized in the lab of Paul Trippier, Ph.D., that show the effects of protecting human neurons in a dish from a form of cell death common in neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease.
Trippier is an assistant professor for the Department of Pharmaceutical Sciences at the Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy in Amarillo. He is collaborating with the lab of Abraham Al-Ahmad, an assistant professor in the same TTUHSC School of Pharmacy department.
Trippier said the TTUHSC research team grew functional human neurons from stem cells and then treated them with the synthesized compounds. When cell death was induced, many more neurons that had been treated with the new compounds survived than did those that were not treated.
“These compounds are in the early stages of drug discovery, but they show promise for the treatment of many different types of neurodegenerative disease,” Trippier said. “The advantage to this study is the use of stem cell-derived functional human neurons. Many studies have identified compounds that can protect either neuron-like cells or mouse neurons, but they rarely carry forward to show effect in humans.”
As the compounds developed in his and Al-Alamad’s labs already show effect in human neurons, Trippier said they are much more likely to be effective in patients, albeit in the distant future.
Related Stories
Noise-Induced Hearing Loss in Rural Adolescents
Leigh Ann Reel, Au.D., Ph.D., CCC-A, discussed the causes and prevention strategies for noise-induced hearing loss, particularly for adolescents in rural areas.
Willed Body Memorial Service Honors Those Who Donated
On Memorial Day each May, a service is conducted at the Texas Tech University Health Sciences Center Institute of Anatomical Sciences to pay respect to the Willed Body Program donors and their families.
Molecular Pathology Preceptorship: Unmatched Value and Experience
Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.
Recent Stories
Logsdon Receives Grant to Study Vascular Side of Traumatic Brain Injuries
Supported by a three-year, $578,211 grant from the National Institutes of Health-National Institute on Aging, Aric F. Logsdon, Ph.D., will study how brain endothelial cells, or blood vessels within the brain, handle the stressors of neuroinflammation.
Historic collaboration brings shipping container-based health care clinic to Jeff Davis County
Texas A&M Health and TTUHSC joined with the student-led organization, Texas A&M BUILD—along with local leadership and other collaborators—to unveil a new, innovative medical care facility for a Trans-Pecos region rural community: a 40-foot, retro-fitted shipping container.
Improving Health Care Access, Education Through Research
The service area for TTUHSC, a recognized leader in academic health and biomedical research training, encompasses 121 Texas counties.